Brooks Gabriel 4

What Happened
Brooks Gabriel, Chief Medical Officer of Solid Biosciences (SLDB), disposed of 12,616 shares on 2026-02-04 in an open-market/private sale reported as a sale (S). The transaction was reported at a weighted average price of $6.44 per share for proceeds of approximately $81,271.

Key Details

• Transaction date: 2026-02-04; Form 4 filed 2026-02-06 (filed timely within the 2-business-day window).
• Shares sold: 12,616; weighted average price: $6.44; reported price range: $6.28–$6.60 (sales executed in multiple trades).
• Reason / footnote: Sale was a sell-to-cover to satisfy withholding taxes on vested restricted stock units, per a durable automatic sale instruction letter adopted Aug 15, 2024; not a discretionary trade by Dr. Gabriel (Footnote F1).
• Footnote F2: Reporting person can provide a breakdown of the number of shares sold at each price within the stated range upon request.
• Shares owned after transaction: Not specified in the provided filing.

Context
This was a routine sell-to-cover tax withholding following RSU vesting, which is common and generally not a directional market signal. The filing appears timely.